In fact, some malignancies, such as non-small-cell lung, breast, prostate, and colorectal cancer, exhibit an abnormal activation of PI3K/AKT/mTOR signaling (Jiang et al., 2020; Yu et al., 2022). Here, MTOR is linked to colorectal cancer.